NASDAQ Composite opens in less than one hour and Catalyst Pharmaceuticals’s premarket value is already 2.08% up.
The last session, nASDAQ Composite ended with Catalyst Pharmaceuticals sliding 2.03% to $3.37. NASDAQ Composite fell 0.38% to $12,850.22, following last session’s downward trend on what was a somewhat negative trend trading session.
Catalyst Pharmaceuticals’s last close was $3.44, 56.68% under its 52-week high of $5.28.
Catalyst Pharmaceuticals’s Revenue
Year-on-year quarterly revenue growth declined by 5.1%, now sitting on 118.18M for the twelve trailing months.
Catalyst Pharmaceuticals’s last day, last week, and last month’s average volatility was a positive 0.58%, a negative 0.81%, and a negative 0.06%, respectively.
Catalyst Pharmaceuticals’s last day, last week, and last month’s high and low average amplitude percentage was 4.11%, 3.95%, and 5.23%, respectively.